Status:
RECRUITING
Bern Birth Cohort / Trajectory of Microbiota Maturation in Healthy Bern Infants - a Network Approach
Lead Sponsor:
Insel Gruppe AG, University Hospital Bern
Collaborating Sponsors:
University of Bern
Conditions:
Maturation of the Healthy Infant Intestinal Microbiota
Microbial Colonization
Eligibility:
FEMALE
18-45 years
Brief Summary
Background: Intestinal microbiota composition is fundamental to human health and undergoes critical changes within the first two years of life. Factors probably influencing the microbiota are the mate...
Detailed Description
Methods for sample analysis: For the primary objective and outcome/ endpoint of the study, bacterial content of infant stool will be analyzed by: * Mass spectrometry to assess intestinal content (me...
Eligibility Criteria
Inclusion
- Signed informed consent.
- Ability to understand and follow study procedures and understand informed consent
- From week 20 of pregnancy until birth
- General good health, i.e. absence of major severe medical/ surgical/ psychiatric condition requiring ongoing management. Minor well controlled conditions (e.g. medically controlled arterial hypertension, occupational asthma, gestational diabetes mellitus) may be present.
- Absence of known severe embryonal pathology, expected normal pregnancy (e.g. minor conditions including twin/ triplet pregnancy, final pelvic position may be present)
- Age 18-45 years.
Exclusion
- • Participation in another clinical study interfering with study procedures.
Key Trial Info
Start Date :
May 7 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 3 2035
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT04447742
Start Date
May 7 2020
End Date
March 3 2035
Last Update
November 12 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital of Bern - Insel Spital
Bern, Switzerland, 3010